FDA ANDA · ANDA203171
TELMISARTAN
Sponsor: TORRENT
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA203171
TYPE
ANDA
ORIGINAL APPROVAL
2014-07-07
LATEST ACTION
2026-10-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
TELMISARTANPrescription
TELMISARTAN 80MG · TABLET · ORAL
TELMISARTANPrescription
TELMISARTAN 20MG · TABLET · ORAL
TELMISARTANPrescription
TELMISARTAN 40MG · TABLET · ORAL
Approval history
2026-10-08Labeling · Supplement 13 · standardAP
2026-10-08Labeling · Supplement 12 · standardAP
2019-08-07Labeling · Supplement 6 · standardAP
2015-03-02Labeling · Supplement 1 · standardAP
2015-03-02Labeling · Supplement 2 · standardAP
2014-07-07UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →